Atovaquone Maintenance Therapy Prevents Reactivation of Toxoplasmic Encephalitis in a Murine Model of Reactivated Toxoplasmosis

Acute therapy with pyrimethamine plus sulfadiazine is the treatment of choice for reactivated toxoplasmic encephalitis (TE). Acute therapy is followed by lifelong maintenance therapy (secondary prophylaxis) with the same drugs at lower dosages. The use of pyrimethamine plus sulfadiazine is hampered...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Antimicrob Agents Chemother
Päätekijät: Dunay, Ildiko R., Heimesaat, Markus M., Bushrab, Faris Nadiem, Müller, Rainer H., Stocker, Hartmut, Arasteh, Keikawus, Kurowski, Michael, Fitzner, Rudolf, Borner, Klaus, Liesenfeld, Oliver
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology (ASM) 2004
Aiheet:
Experimental Therapeutics
Linkit:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC529229/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15561866/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.12.4848-4854.2004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia